XML 28 R67.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 15 - Condensed Consolidating Financial Information Of Guarantor Subsidiaries (Detail) - Condensed Consolidating Cash Flow Information (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Aug. 19, 2011
Nov. 30, 2011
Nov. 30, 2010
May 31, 2011
May 31, 2010
Net cash provided by (used in) operating activities $ 25,588 $ 1,883 $ 47,729    
Net cash used in investing activities (2,265) (1,941,900) (3,629)    
Net cash 66 1,655,165 202    
Effect of exchange rate changes on cash and cash equivalents (3,029) (1,236) 1,387    
Increase (decrease) in cash and cash equivalents 20,360 (286,088) 45,689    
Cash and cash equivalents 322,963 36,875 248,338 302,603 202,649
Beginning Balance [Member] | Immucor Inc [Member] | Successor [Member]
         
Cash and cash equivalents   314,304      
Beginning Balance [Member] | Immucor Inc [Member] | Predecessor [Member]
         
Cash and cash equivalents       250,386 171,144
Beginning Balance [Member] | Guarantor [Member] | Successor [Member]
         
Cash and cash equivalents   (89)      
Beginning Balance [Member] | Guarantor [Member] | Predecessor [Member]
         
Cash and cash equivalents       (80) (278)
Beginning Balance [Member] | Non-Guarantors [Member] | Successor [Member]
         
Cash and cash equivalents   8,748      
Beginning Balance [Member] | Non-Guarantors [Member] | Predecessor [Member]
         
Cash and cash equivalents       52,297 31,783
Beginning Balance [Member] | Total [Member] | Successor [Member]
         
Cash and cash equivalents   322,963      
Beginning Balance [Member] | Total [Member] | Predecessor [Member]
         
Cash and cash equivalents       302,603 202,649
Ending Balance [Member] | Immucor Inc [Member] | Successor [Member]
         
Cash and cash equivalents   26,806      
Ending Balance [Member] | Immucor Inc [Member] | Predecessor [Member]
         
Cash and cash equivalents 314,304   208,212    
Ending Balance [Member] | Guarantor [Member] | Successor [Member]
         
Cash and cash equivalents   (89)      
Ending Balance [Member] | Guarantor [Member] | Predecessor [Member]
         
Cash and cash equivalents (89)   (100)    
Ending Balance [Member] | Non-Guarantors [Member] | Successor [Member]
         
Cash and cash equivalents   10,158      
Ending Balance [Member] | Non-Guarantors [Member] | Predecessor [Member]
         
Cash and cash equivalents 8,748   40,226    
Ending Balance [Member] | Total [Member] | Successor [Member]
         
Cash and cash equivalents   36,875      
Ending Balance [Member] | Total [Member] | Predecessor [Member]
         
Cash and cash equivalents 322,963   248,338    
Immucor Inc [Member] | Successor [Member]
         
Net cash provided by (used in) operating activities   (1,664)      
Net cash used in investing activities   (1,941,000)      
Net cash   1,655,166      
Increase (decrease) in cash and cash equivalents   (287,498)      
Cash and cash equivalents   26,806      
Immucor Inc [Member] | Predecessor [Member]
         
Net cash provided by (used in) operating activities 64,243   39,485    
Net cash used in investing activities (393)   (2,619)    
Net cash 68   202    
Increase (decrease) in cash and cash equivalents 63,918   37,068    
Cash and cash equivalents       250,386  
Guarantor [Member] | Successor [Member]
         
Net cash provided by (used in) operating activities   199      
Net cash used in investing activities   (199)      
Guarantor [Member] | Predecessor [Member]
         
Net cash provided by (used in) operating activities 144   379    
Net cash used in investing activities (153)   (201)    
Increase (decrease) in cash and cash equivalents (9)   178    
Non-Guarantors [Member] | Successor [Member]
         
Net cash provided by (used in) operating activities   13,581      
Net cash used in investing activities   (701)      
Net cash   (10,753)      
Effect of exchange rate changes on cash and cash equivalents   (717)      
Increase (decrease) in cash and cash equivalents   1,410      
Cash and cash equivalents   10,158      
Non-Guarantors [Member] | Predecessor [Member]
         
Net cash provided by (used in) operating activities (13,821)   7,262    
Net cash used in investing activities (1,719)   (809)    
Net cash (25,085)        
Effect of exchange rate changes on cash and cash equivalents (2,924)   1,990    
Increase (decrease) in cash and cash equivalents (43,549)   8,443    
Cash and cash equivalents       52,297  
Corporate Elimination [Member] | Successor [Member]
         
Net cash provided by (used in) operating activities   (10,233)      
Net cash   10,752      
Effect of exchange rate changes on cash and cash equivalents   (519)      
Cash and cash equivalents   (89)      
Corporate Elimination [Member] | Predecessor [Member]
         
Net cash provided by (used in) operating activities (24,978)   603    
Net cash 25,083        
Effect of exchange rate changes on cash and cash equivalents (105)   (603)    
Cash and cash equivalents       (80)  
Total [Member] | Successor [Member]
         
Net cash provided by (used in) operating activities   1,883      
Net cash used in investing activities   (1,941,900)      
Net cash   1,655,165      
Effect of exchange rate changes on cash and cash equivalents   (1,236)      
Increase (decrease) in cash and cash equivalents   (286,088)      
Cash and cash equivalents   36,875      
Total [Member] | Predecessor [Member]
         
Net cash provided by (used in) operating activities 25,588   47,729    
Net cash used in investing activities (2,265)   (3,629)    
Net cash 66   202    
Effect of exchange rate changes on cash and cash equivalents (3,029)   1,387    
Increase (decrease) in cash and cash equivalents 20,360   45,689    
Cash and cash equivalents       $ 302,603